National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: Analytical issues for biomarkers of heart failure.

نویسندگان

  • Fred S Apple
  • Alan H B Wu
  • Allan S Jaffe
  • Mauro Panteghini
  • Robert H Christenson
  • Christopher P Cannon
  • Gary Francis
  • Robert L Jesse
  • David A Morrow
  • L Kristen Newby
  • Alan B Storrow
  • W H Wilson Tang
  • Franca Pagani
  • Jillian Tate
  • Jordi Ordonez-Llanos
  • Johannes Mair
چکیده

I. Overview of Analytical Issues for Heart Failure Biomarkers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .e95 A. Background. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .e95 II. Analytical Biomarker Issues . . . . . . . . . . . . . . . . . . .e96 A. Issues Related to B-Type Natriuretic Peptide (BNP) and N-Terminal proB-Type Natriuretic Peptide (NTproBNP) Measurement. . . . . . . . . . . . . . . . . . . . .e96 1. Scope of BNP and NT-proBNP Assays . . . . .e96 2. Biological Implications for Assays of BNP and NT-proBNP . . . . . . . . . . . . . . . . . . . . . . . . . . .e97 3. Specimen Collection for BNP and NT-proBNP Measurement . . . . . . . . . . . . . . . . . . . . . . . . . .e97 4. Clinical Impact of BNP and NT-proBNP Metabolism . . . . . . . . . . . . . . . . . . . . . . . . . . .e97 5. Other Effects and Considerations for BNP and NT-proBNP Values . . . . . . . . . . . . . . . . . . . . .e97 III. References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .e98

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes.

I. OVERVIEW OF ANALYTICAL ISSUES FOR ACUTE CORONARY SYNDROME (ACS) BIOMARKERS ............................................................548 A. Analytical Issues: Background ..........................548 II. ANALYTICAL BIOMARKER ISSUES....................548 A. Cardiac Troponin Specifications .......................548 B. Cardiac Biomarker Turnaround........................549 C. Biomarkers No...

متن کامل

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Utilization of Biochemical Markers in Acute Coronary Syndromes and Heart Failure.

Preamble The National Academy of Clinical Biochemistry’s (NACB) Laboratory Medicine Practice Guidelines (LMPG) for use of cardiac markers in coronary artery diseases were published in July 19991. Since production of this initial document, numerous published studies and presented data have added significantly to the knowledge base for biochemical markers of cardiac injury. This increased knowled...

متن کامل

IFCC Committee on Standardization of Markers of Cardiac Damage: premises and project presentation. International Federation of Clinical Chemistry and Laboratory Medicine.

The field of biochemical markers of cardiac damage is in a dynamic state, with new applications continually appearing and new assays and markers being developed. These significant and sudden advancements in the development of new biochemical assays have led however to several analytical and interpretative problems. In this situation, it is essential that a uniform and rigorous outlook be mainta...

متن کامل

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical utilization of cardiac biomarker testing in heart failure.

I. Overview of Heart Failure. . . . . . . . . . . . . . . . . . . . . . .e99 A. Context of Biochemical Marker Testing in Heart Failure. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .e99 B. Background and Definition of Terms . . . . . . . . . .e100 C. B-type Natriuretic Peptide (BNP) and AminoTerminal proB-Type Natriuretic Peptide (NT-proBNP) Metabolism and Measurement . . . .e100 I...

متن کامل

National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines: emerging biomarkers for primary prevention of cardiovascular disease.

BACKGROUND Heart disease and stroke continue to be the leading causes of death in the US. As a result, investigators continue to look for new and emerging biomarkers of disease risk. Because many of these emerging biomarkers are not as well documented as those of conventional lipid and lipoprotein risk factors, their value in clinical practice needs to be critically appraised and appropriate gu...

متن کامل

ذخیره در منابع من

ذخیره در منابع من قبلا به منابع من ذحیره شده

{@ msg_add @}


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Circulation

دوره 116 5  شماره 

صفحات  -

تاریخ انتشار 2007